13F Data
13F filer · CIK 1802967

Tao Capital Management LP

SAN FRANCISCO, CA · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$1.9B
+$1.8B vs prior
Positions
6
New / sold out
1 / 3
Added / reduced
1 / 1
Turnover
5.6%
buys $1.8B · sells $57.9M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewSpace Exploration Technologies Corp.+10,644,340–+$1.8B
Added10x Genomics, Inc.+72,607+34.4%+$2.8M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedTwist Bioscience Corporation-350,000-42.2%$-36.0M
Sold outOuster, Inc.-845,316-100.0%$-15.5M
Sold out908 Devices Inc.-568,981-100.0%$-3.5M
Sold outWarby Parker Inc.-134,473-100.0%$-2.8M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $203.0MQ1 2020: $213.0MQ2 2020: $253.0MQ3 2020: $310.2MQ4 2020: $406.7MQ1 2021: $346.3MQ2 2021: $435.8MQ3 2021: $375.3MQ4 2021: $327.3MQ1 2022: $274.2MQ2 2022: $144.5MQ3 2022: $152.5MQ4 2022: $133.0MQ1 2023: $125.7MQ2 2023: $136.6MQ3 2023: $129.1MQ4 2023: $109.3MQ1 2024: $105.5MQ2 2024: $122.0MQ3 2024: $110.4MQ4 2024: $143.3MQ1 2025: $116.1MQ2 2025: $136.4MQ3 2025: $132.2MQ4 2025: $116.2MQ1 2026: $118.8MQ2 2026: $1.9B
Q4 2019Q2 2026

Holdings · Q2 2026